Trials / Completed
CompletedNCT01023945
A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus
A Phase 1, Randomized, Double-blind, Placebo Controlled, Monotherapy Study to Assess the Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the pharmacodynamic profile (blood glucose and urinary glucose excursion) of ASP1941 in patients with type 2 diabetes mellitus. Safety, tolerability and pharmacokinetics are also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | oral |
| DRUG | Placebo | oral |
Timeline
- Start date
- 2009-11-07
- Primary completion
- 2010-03-26
- Completion
- 2010-03-26
- First posted
- 2009-12-02
- Last updated
- 2024-11-12
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01023945. Inclusion in this directory is not an endorsement.